Twinbeech Capital LP Bausch Health Companies Inc. Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $850,955 - $2.85 Million	120,532 New	120,532 $1.01 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $468,655 - $602,959	-21,697 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $499,031 - $629,429	21,697 New	21,697 $599,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $355,603 - $547,965	-26,717 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $346,786 - $808,189	26,717 New	26,717 $414,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.